Advertisement
Screener

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) Increase (Decrease) in Inventories

2.8 / 5 stars · 68/120 Roast Me

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Increase (Decrease) in Inventories

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Increase (Decrease) in Inventories of -$43.75 million for the 6-month period ending 2026-06-27, per its 10-Q filed 2026-08-05.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-05

  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in inventories for the quarter ending 2026-06-27 was -$17.74M.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in inventories for the quarter ending 2026-03-28 was -$26.00M, a 218.84% decline year-over-year.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in inventories for the quarter ending 2025-12-27 was $3.50M.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in inventories for the quarter ending 2025-09-27 was $31.33M.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in inventories for fiscal 2025 was $48.78M.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in inventories for fiscal 2024 was -$16.80M, a 126.97% decline from fiscal 2023.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in inventories for fiscal 2023 was $62.30M, a 20.66% decline from fiscal 2022.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in inventories for fiscal 2022 was $78.52M, a 212.11% increase from fiscal 2021.
Period endIncrease (Decrease) in Inventories 3 monthIncrease (Decrease) in Inventories 6 monthIncrease (Decrease) in Inventories 9 monthIncrease (Decrease) in Inventories 12 month
2026-06-27-$17.74M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
-$43.75M
10-Q · filed 2026-08-05
-$40.25M
derived: sum of 3 quarters · filed 2026-08-05
-$8.92M
derived: sum of 4 quarters · filed 2026-08-05
2026-03-28-$26.00M
10-Q · filed 2026-05-07
-$22.51M
derived: sum of 2 quarters · filed 2026-05-07
$8.82M
derived: sum of 3 quarters · filed 2026-05-07
$891.00K
derived: sum of 4 quarters · filed 2026-08-05
2025-12-27$3.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18
$34.82M
derived: sum of 2 quarters · filed 2026-02-18
$26.89M
derived: sum of 3 quarters · filed 2026-08-05
$48.78M
10-K · filed 2026-02-18
2025-09-27$31.33M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
$23.40M
derived: sum of 2 quarters · filed 2026-08-05
$45.28M
10-Q · filed 2025-11-05
$42.27M
derived: sum of 4 quarters · filed 2026-08-05
2025-06-28-$7.93M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$13.95M
10-Q · filed 2026-08-05
$10.94M
derived: sum of 3 quarters · filed 2026-08-05
$6.90M
derived: sum of 4 quarters · filed 2026-08-05
2025-03-29$21.88M
10-Q · filed 2026-05-07
$18.87M
derived: sum of 2 quarters · filed 2026-05-07
$14.83M
derived: sum of 3 quarters · filed 2026-05-07
$10.68M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-28-$3.02M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18
-$7.05M
derived: sum of 2 quarters · filed 2026-02-18
-$11.20M
derived: sum of 3 quarters · filed 2026-02-18
-$16.80M
10-K · filed 2026-02-18
2024-09-28-$4.04M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
-$8.19M
derived: sum of 2 quarters · filed 2025-11-05
-$13.79M
10-Q · filed 2025-11-05
$4.39M
derived: sum of 4 quarters · filed 2026-02-18
2024-06-29-$4.15M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06
-$9.75M
10-Q · filed 2025-08-06
$8.43M
derived: sum of 3 quarters · filed 2026-02-18
$19.88M
derived: sum of 4 quarters · filed 2026-02-18
2024-03-30-$5.60M
10-Q · filed 2025-05-07
$12.57M
derived: sum of 2 quarters · filed 2026-02-18
$24.03M
derived: sum of 3 quarters · filed 2026-02-18
$48.11M
derived: sum of 4 quarters · filed 2026-02-18
2023-12-30$18.18M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18
$29.63M
derived: sum of 2 quarters · filed 2026-02-18
$53.71M
derived: sum of 3 quarters · filed 2026-02-18
$62.30M
10-K · filed 2026-02-18
2023-09-30$11.46M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06
$35.54M
derived: sum of 2 quarters · filed 2024-11-06
$44.13M
10-Q · filed 2024-11-06
$46.37M
derived: sum of 4 quarters · filed 2025-02-19
2023-07-01$24.08M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07
$32.67M
10-Q · filed 2024-08-07
$34.91M
derived: sum of 3 quarters · filed 2025-02-19
$47.47M
derived: sum of 4 quarters · filed 2025-02-19
2023-04-01$8.59M
10-Q · filed 2024-05-09
$10.83M
derived: sum of 2 quarters · filed 2025-02-19
$23.39M
derived: sum of 3 quarters · filed 2025-02-19
$63.95M
derived: sum of 4 quarters · filed 2025-02-19
2022-12-31$2.24M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19
$14.80M
derived: sum of 2 quarters · filed 2025-02-19
$55.36M
derived: sum of 3 quarters · filed 2025-02-19
$78.52M
10-K · filed 2025-02-19
2022-09-24$12.56M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08
$53.12M
derived: sum of 2 quarters · filed 2023-11-08
$76.28M
10-Q · filed 2023-11-08
$95.80M
derived: sum of 4 quarters · filed 2024-02-14
2022-06-25$40.56M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
$63.73M
10-Q · filed 2023-08-09
$83.25M
derived: sum of 3 quarters · filed 2024-02-14
$81.78M
derived: sum of 4 quarters · filed 2024-02-14
2022-03-26$23.16M
10-Q · filed 2023-05-11
$42.68M
derived: sum of 2 quarters · filed 2024-02-14
$41.22M
derived: sum of 3 quarters · filed 2024-02-14
$36.92M
derived: sum of 4 quarters · filed 2024-02-14
2021-12-25$19.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14
$18.05M
derived: sum of 2 quarters · filed 2024-02-14
$13.76M
derived: sum of 3 quarters · filed 2024-02-14
$25.16M
10-K · filed 2024-02-14
2021-09-25-$1.47M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02
-$5.76M
derived: sum of 2 quarters · filed 2022-11-02
$5.64M
10-Q · filed 2022-11-02
$9.96M
derived: sum of 4 quarters · filed 2023-02-22
2021-06-26-$4.30M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03
$7.11M
10-Q · filed 2022-08-03
$11.43M
derived: sum of 3 quarters · filed 2023-02-22
$23.59M
derived: sum of 4 quarters · filed 2023-02-22
2021-03-27$11.40M
10-Q · filed 2022-05-04
$15.73M
derived: sum of 2 quarters · filed 2023-02-22
$27.88M
derived: sum of 3 quarters · filed 2023-02-22
$33.86M
derived: sum of 4 quarters · filed 2023-02-22
2020-12-26$4.32M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22
$16.48M
derived: sum of 2 quarters · filed 2023-02-22
$22.45M
derived: sum of 3 quarters · filed 2023-02-22
$18.38M
10-K · filed 2023-02-22
2020-09-26$12.15M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03
$18.13M
derived: sum of 2 quarters · filed 2021-11-03
$14.05M
10-Q · filed 2021-11-03
$22.47M
derived: sum of 4 quarters · filed 2022-02-16
2020-06-27$5.98M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04
$1.90M
10-Q · filed 2021-08-04
$10.32M
derived: sum of 3 quarters · filed 2022-02-16
$20.73M
derived: sum of 4 quarters · filed 2022-02-16
2020-03-28-$4.08M
10-Q · filed 2021-05-04
$4.34M
derived: sum of 2 quarters · filed 2022-02-16
$14.76M
derived: sum of 3 quarters · filed 2022-02-16
$14.80M
derived: sum of 4 quarters · filed 2022-02-16
2019-12-28$8.42M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16
$18.83M
derived: sum of 2 quarters · filed 2022-02-16
$18.88M
derived: sum of 3 quarters · filed 2022-02-16
$21.40M
10-K · filed 2022-02-16
2019-09-28$10.42M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29
$10.46M
derived: sum of 2 quarters · filed 2020-10-29
$12.98M
10-Q · filed 2020-10-29
$15.98M
derived: sum of 4 quarters · filed 2021-02-17
2019-06-29$45.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05
$2.56M
10-Q · filed 2020-08-05
$5.56M
derived: sum of 3 quarters · filed 2021-02-17
$8.46M
derived: sum of 4 quarters · filed 2021-02-17
2019-03-30$2.52M
10-Q · filed 2020-05-07
$5.52M
derived: sum of 2 quarters · filed 2021-02-17
$8.41M
derived: sum of 3 quarters · filed 2021-02-17
$12.36M
derived: sum of 4 quarters · filed 2021-02-17
2018-12-29$3.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17
$5.89M
derived: sum of 2 quarters · filed 2021-02-17
$9.84M
derived: sum of 3 quarters · filed 2021-02-17
$13.34M
10-K · filed 2021-02-17
2018-09-29$2.90M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06
$6.84M
derived: sum of 2 quarters · filed 2019-11-06
$10.34M
10-Q · filed 2019-11-06
$18.68M
derived: sum of 4 quarters · filed 2020-02-11
2018-06-30$3.94M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31
$7.44M
10-Q · filed 2019-07-31
$15.78M
derived: sum of 3 quarters · filed 2020-02-11
$17.54M
derived: sum of 4 quarters · filed 2020-02-11
2018-03-31$3.50M
10-Q · filed 2019-05-07
$11.84M
derived: sum of 2 quarters · filed 2020-02-11
$13.59M
derived: sum of 3 quarters · filed 2020-02-11
$18.75M
derived: sum of 4 quarters · filed 2020-02-11
2017-12-30$8.34M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-11
$10.09M
derived: sum of 2 quarters · filed 2020-02-11
$15.24M
derived: sum of 3 quarters · filed 2020-02-11
$17.84M
10-K · filed 2020-02-11
2017-09-30$1.75M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07
$6.91M
derived: sum of 2 quarters · filed 2018-11-07
$9.50M
10-Q · filed 2018-11-07
$9.17M
derived: sum of 4 quarters · filed 2019-02-13
2017-07-01$5.15M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08
$7.75M
10-Q · filed 2018-08-08
$7.42M
derived: sum of 3 quarters · filed 2019-02-13
$10.08M
derived: sum of 4 quarters · filed 2019-02-13
2017-04-01$2.59M
10-Q · filed 2018-05-10
$2.26M
derived: sum of 2 quarters · filed 2019-02-13
$4.93M
derived: sum of 3 quarters · filed 2019-02-13
$3.53M
derived: sum of 4 quarters · filed 2019-02-13
2016-12-31-$331.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13
$2.34M
derived: sum of 2 quarters · filed 2019-02-13
$940.00K
derived: sum of 3 quarters · filed 2019-02-13
$4.02M
10-K · filed 2019-02-13
2016-09-24$2.67M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
$1.27M
derived: sum of 2 quarters · filed 2017-11-09
$4.35M
10-Q · filed 2017-11-09
$518.00K
derived: sum of 4 quarters · filed 2018-02-13
2016-06-25-$1.40M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09
$1.69M
10-Q · filed 2017-08-09
-$2.15M
derived: sum of 3 quarters · filed 2018-02-13
-$3.34M
derived: sum of 4 quarters · filed 2018-02-13
2016-03-26$3.08M
10-Q · filed 2017-05-10
-$753.00K
derived: sum of 2 quarters · filed 2018-02-13
-$1.95M
derived: sum of 3 quarters · filed 2018-02-13
$148.00K
derived: sum of 4 quarters · filed 2018-02-13
2015-12-26-$3.83M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13
-$5.03M
derived: sum of 2 quarters · filed 2018-02-13
-$2.93M
derived: sum of 3 quarters · filed 2018-02-13
-$3.36M
10-K · filed 2018-02-13
2015-09-26-$1.19M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02
$901.00K
derived: sum of 2 quarters · filed 2016-11-02
$470.00K
10-Q · filed 2016-11-02
-$1.15M
derived: sum of 4 quarters · filed 2017-02-14
2015-06-27$2.09M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03
$1.66M
10-Q · filed 2016-08-03
$45.00K
derived: sum of 3 quarters · filed 2017-02-14
$2.12M
derived: sum of 4 quarters · filed 2017-02-14
2015-03-28-$431.00K
10-Q · filed 2016-05-04
-$2.05M
derived: sum of 2 quarters · filed 2017-02-14
$23.00K
derived: sum of 3 quarters · filed 2017-02-14
$231.00K
derived: sum of 4 quarters · filed 2017-02-14
2014-12-27-$1.62M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14
$454.00K
derived: sum of 2 quarters · filed 2017-02-14
$662.00K
derived: sum of 3 quarters · filed 2017-02-14
$2.96M
10-K · filed 2017-02-14
2014-09-27$2.07M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04
$2.28M
derived: sum of 2 quarters · filed 2015-11-04
$4.57M
10-Q · filed 2015-11-04
$7.59M
derived: sum of 4 quarters · filed 2016-02-12
2014-06-28$208.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30
$2.50M
10-Q · filed 2015-07-30
$5.52M
derived: sum of 3 quarters · filed 2016-02-12
$3.19M
derived: sum of 4 quarters · filed 2016-02-12
2014-03-29$2.29M
10-Q · filed 2015-04-30
$5.31M
derived: sum of 2 quarters · filed 2016-02-12
$2.98M
derived: sum of 3 quarters · filed 2016-02-12
$6.79M
derived: sum of 4 quarters · filed 2016-02-12
2013-12-28$3.02M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12
$689.00K
derived: sum of 2 quarters · filed 2016-02-12
$4.49M
derived: sum of 3 quarters · filed 2016-02-12
$1.57M
10-K · filed 2016-02-12
2013-09-28-$2.33M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30
$1.48M
derived: sum of 2 quarters · filed 2014-10-30
-$1.45M
10-Q · filed 2014-10-30
-$4.41M
derived: sum of 4 quarters · filed 2015-02-17
2013-06-29$3.80M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07
$882.00K
10-Q · filed 2014-08-07
-$2.09M
derived: sum of 3 quarters · filed 2015-02-17
-$1.11M
derived: sum of 4 quarters · filed 2015-02-17
2013-03-30-$2.92M
10-Q · filed 2014-04-30
-$5.89M
derived: sum of 2 quarters · filed 2015-02-17
-$4.91M
derived: sum of 3 quarters · filed 2015-02-17
-$395.00K
derived: sum of 4 quarters · filed 2015-02-17
2012-12-29-$2.97M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17
-$1.99M
derived: sum of 2 quarters · filed 2015-02-17
$2.53M
derived: sum of 3 quarters · filed 2015-02-17
-$785.00K
10-K · filed 2015-02-17
2012-09-29$977.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30
$5.50M
derived: sum of 2 quarters · filed 2013-10-30
$2.18M
10-Q · filed 2013-10-30
$5.51M
derived: sum of 4 quarters · filed 2014-02-25
2012-06-30$4.52M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-31
$1.21M
10-Q · filed 2013-07-31
$4.53M
derived: sum of 3 quarters · filed 2014-02-25
-$998.00K
derived: sum of 4 quarters · filed 2014-02-25
2012-03-31-$3.31M
10-Q · filed 2013-05-08
$12.00K
derived: sum of 2 quarters · filed 2014-02-25
-$5.52M
derived: sum of 3 quarters · filed 2014-02-25
-$2.74M
derived: sum of 4 quarters · filed 2014-02-25
2011-12-31$3.32M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25
-$2.20M
derived: sum of 2 quarters · filed 2014-02-25
$570.00K
derived: sum of 3 quarters · filed 2014-02-25
-$3.77M
10-K · filed 2014-02-25
2011-09-24-$5.53M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01
-$2.75M
derived: sum of 2 quarters · filed 2012-11-01
-$7.09M
10-Q · filed 2012-11-01
-$7.28M
derived: sum of 4 quarters · filed 2013-02-27
2011-06-25$2.77M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07
-$1.56M
10-Q · filed 2012-08-07
-$1.75M
derived: sum of 3 quarters · filed 2013-02-27
$292.00K
derived: sum of 4 quarters · filed 2013-02-27
2011-03-26-$4.34M
10-Q · filed 2012-05-04
-$4.52M
derived: sum of 2 quarters · filed 2013-02-27
-$2.48M
derived: sum of 3 quarters · filed 2013-02-27
-$2.56M
derived: sum of 4 quarters · filed 2013-02-27
2010-12-25-$185.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27
$1.85M
derived: sum of 2 quarters · filed 2013-02-27
$1.78M
derived: sum of 3 quarters · filed 2013-02-27
-$1.99M
10-K · filed 2013-02-27
2010-09-25$2.04M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02
$1.96M
derived: sum of 2 quarters · filed 2011-11-02
-$1.80M
10-Q · filed 2011-11-02
$936.00K
derived: sum of 4 quarters · filed 2012-02-27
2010-06-26-$78.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-03
-$3.84M
10-Q · filed 2011-08-03
-$1.10M
derived: sum of 3 quarters · filed 2012-02-27
$1.31M
derived: sum of 4 quarters · filed 2012-02-27
2010-03-27-$3.77M
10-Q · filed 2011-05-04
-$1.02M
derived: sum of 2 quarters · filed 2012-02-27
$1.39M
derived: sum of 3 quarters · filed 2012-02-27
2009-12-26$2.74M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27
$5.15M
derived: sum of 2 quarters · filed 2012-02-27
$4.38M
10-K · filed 2012-02-27
2009-09-26$2.41M
derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-04
$1.64M
10-Q · filed 2010-11-04
2009-06-27-$778.00K
10-Q · filed 2010-08-03
2008-12-27$9.67M
10-K · filed 2011-02-23

Similar stocks

Stock NameCountryMarket CapPE Ratio
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
INCYTE CORP (INCY)United States$24.855B13.14
Absci Corp (ABSI)United States$1.775B-14.92
OmniAb, Inc. (OABI)United States$0.698B-8.05
NRC HEALTH (NRC)United States$0.450B42.50
MAXCYTE, INC. (MXCT)United States$0.124B-3.68
bioAffinity Technologies, Inc. (BIAF)United States$0.063B
OneMedNet Corp (ONMD)$0.042B
iSpecimen Inc. (ISPC)United States$0.003B
FOXO TECHNOLOGIES INC. (FOXO)United States$0.000B-277.71